CRON
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
2024-04-02–present
Chairman
Cronos Group Inc. (CRON)Equibles does not estimate personal net worth.
Get an email with a short summary when Cronos Group Inc. publishes a filing, an earnings call transcript or a press release.
Get CRON alertsRan Gorelik is recorded as Chairman at Cronos Group Inc. (CRON) since April 2, 2024. Cronos Group Inc. reported in an 8-K filed April 3, 2024 that Ran Gorelik was appointed Chairman of Cronos Israel, effective April 2, 2024. The proxy statement of Cronos Group Inc. reports total compensation of $621,371 for Ran Gorelik in fiscal 2023, including a base salary of $244,440. Disclosed compensation is on record for 3 fiscal years. Cronos Group Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Cronos Group Inc. includes Michael Gorenstein (CEO, Chairman and Board Member), Michael Gorenstein Chairman (CEO), Anna Shlimak (CFO) and 7 others.
“Mr. Gorelik will become Chairman of Cronos Israel and will no longer serve as General Manager (Cronos Israel).”
2024-04-02–present
Proxy statement
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
CRON
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
2024-04-02–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Cronos Group Inc. (CRON) | General Manager (Cronos Israel) | $244,440 | $621,371 |
| 2022 | Cronos Group Inc. (CRON) | General Manager (Cronos Israel) | $268,380 | $687,369 |
| 2021 | Cronos Group Inc. (CRON) | General Manager (Cronos Israel) | $278,460 | $744,224 |